Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP522034.RA6DVw6eICxD3VlOWr9IEH0ZiJKPveKteSP-r0EmTrbbI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP522034.RA6DVw6eICxD3VlOWr9IEH0ZiJKPveKteSP-r0EmTrbbI130_assertion type Assertion NP522034.RA6DVw6eICxD3VlOWr9IEH0ZiJKPveKteSP-r0EmTrbbI130_head.
- NP522034.RA6DVw6eICxD3VlOWr9IEH0ZiJKPveKteSP-r0EmTrbbI130_assertion description "[Carriage of at least one HSD3B2 intron 3 intron 3 short allele was associated with a significant increased risk for prostate cancer among all subjects (OR = 2.07, 95% CI = 1.08-3.95, P = 0.03) and Caucasians (OR = 2.80, CI = 2.80-7.43, P = 0.04), but not in African Americans (OR = 1.50, CI = 0.62-3.60, P = 0.37).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP522034.RA6DVw6eICxD3VlOWr9IEH0ZiJKPveKteSP-r0EmTrbbI130_provenance.
- NP522034.RA6DVw6eICxD3VlOWr9IEH0ZiJKPveKteSP-r0EmTrbbI130_assertion evidence source_evidence_literature NP522034.RA6DVw6eICxD3VlOWr9IEH0ZiJKPveKteSP-r0EmTrbbI130_provenance.
- NP522034.RA6DVw6eICxD3VlOWr9IEH0ZiJKPveKteSP-r0EmTrbbI130_assertion SIO_000772 17823934 NP522034.RA6DVw6eICxD3VlOWr9IEH0ZiJKPveKteSP-r0EmTrbbI130_provenance.
- NP522034.RA6DVw6eICxD3VlOWr9IEH0ZiJKPveKteSP-r0EmTrbbI130_assertion wasDerivedFrom befree-20140225 NP522034.RA6DVw6eICxD3VlOWr9IEH0ZiJKPveKteSP-r0EmTrbbI130_provenance.
- NP522034.RA6DVw6eICxD3VlOWr9IEH0ZiJKPveKteSP-r0EmTrbbI130_assertion wasGeneratedBy ECO_0000203 NP522034.RA6DVw6eICxD3VlOWr9IEH0ZiJKPveKteSP-r0EmTrbbI130_provenance.